We Think WuXi XDC Cayman (HKG:2268) Can Stay On Top Of Its Debt

Simply Wall StApr 23 02:02 ET

Trending Industry Today: SKB BIO-B Leads Losses In Biotechnology Stocks

Moomoo NewsApr 16 02:20 ET

Hong Kong stocks close | Under the shadow of tariffs, major indices performed unevenly. ZHOU HEI YA surged nearly 8%, leading the Consumer stocks to break through.

① How did Trump's tariff policy lead to a divergence in the Hong Kong stock market? ② Why does HTSC still recommend allocating to Hong Kong stock dividend direction despite tariff disruptions?

cls.cnApr 15 04:44 ET

WUXI XDC (02268.HK) granted 5.39 million restricted shares.

Glory Share on April 14 announced that WUXI XDC (02268.HK), on April 14, 2025, in accordance with the 2024 share plan, approved the grant of 5.39 million restricted shares to 287 grantees (of which three are Directors and the remaining 284 grantees are group employees).

Gelonghui FinanceApr 14 08:57 ET

Trending Industry Today: BEIGENE Leads Gains In Biotechnology Stocks

Moomoo NewsApr 13 23:50 ET

Pharmaceutical stocks generally rose, WUXI XDC (02268) increased by 14.36%. According to Credit Lyonnais, the impact of tariff policies on Innovative Drugs is relatively small.

Jinwu Financial News | Pharmaceutical stocks mostly rose, WUXI XDC (02268) increased by 14.36%, VIVA BIOTECH (01873) rose by 12.3%, He_probe Pharmaceutical (02142) climbed by 11.37%, REMEGEN (09995) went up by 10.51%, WUXI BIO (02269) increased by 7.14%, and WUXI APPTEC (02359) rose by 5.89%. Credit Lyonnais published a research report indicating that due to the limited scale of China-U.S. pharmaceutical trade, the current expectation is that China's Medical Care Industry, especially in the Innovative Drugs sector, is relatively less affected by tariff policies, looking forward to optimization under centralized volume procurement and other policies.

Jingwu Financial NewsApr 9 22:41 ET